Name
Capella University
NURS-FPX4905 Capstone Project for Nursing
Prof. Name
Date
The Longevity Center is a specialized clinical organization focusing on preventive and regenerative medicine, providing services such as hormone optimization, advanced biomarker testing, and cellular therapies. The center primarily serves clients interested in personalized and proactive healthcare strategies. Despite its innovative model, inefficiencies in operational workflows have led to delays in diagnosing patients with complex or ambiguous symptoms. In regenerative medicine, postponements in identifying hormonal imbalances, inflammatory markers, autoimmune triggers, or nutrient deficiencies can compromise treatment effectiveness and patient outcomes (Sierra et al., 2021).
This proposal outlines a structured, systems-level improvement plan that combines workflow redesign with the integration of a Clinical Decision Support System (CDSS). The primary aim is to improve diagnostic speed, enhance clinical accuracy, and reinforce evidence-based regenerative practices.
The central issue at the Longevity Center is prolonged diagnostic turnaround for patients presenting with multifactorial or nonspecific symptoms. Delayed diagnosis subsequently postpones the initiation of therapies such as peptide protocols, bioidentical hormone replacement, platelet-rich plasma (PRP), and stem-cell–based interventions. Since regenerative treatments depend on timely biomarker evaluation, these inefficiencies reduce the effectiveness of therapies and lower patient satisfaction (Sierra et al., 2021).
An internal workflow review highlighted several operational deficiencies:
Fragmented communication among interdisciplinary teams
Absence of standardized triage or prioritization protocols
Manual interpretation of laboratory results without automated alerts
Inconsistent documentation practices
These gaps create variability in clinical processes and increase the likelihood of missed or delayed recognition of critical abnormalities, which directly affects care quality and therapeutic outcomes in precision medicine settings.
Currently, patient intake relies on paper-based forms that are manually transcribed into the Electronic Health Record (EHR). This duplication of effort increases the risk of transcription errors and slows administrative processing. Laboratory results are reviewed manually, and there are no integrated decision support tools to aid differential diagnosis or assist in regenerative protocol selection.
Table 1 summarizes the key operational gaps impacting regenerative care:
Table 1
Current Workflow Limitations
| Clinical Domain | Existing Process | Impact on Regenerative Care |
|---|---|---|
| Patient Intake | Paper forms manually entered into EHR | Increased documentation errors; slower patient throughput |
| Laboratory Review | Manual interpretation without alerts | Delayed recognition of abnormal biomarkers |
| Clinical Decision Support | No CDSS integration | Inconsistent adherence to evidence-based protocols |
| Staff Workflow | Non-standardized processes | Variability in care timelines and treatment readiness |
The lack of standardized diagnostic protocols contributes to inconsistent application of therapies such as hormone modulation, PRP procedures, and cellular rejuvenation treatments.
The recommended intervention involves implementing a standardized digital intake system that integrates directly with the EHR and deploying a CDSS. This approach targets three critical areas: optimizing intake, automating laboratory surveillance, and supporting evidence-guided clinical reasoning. By aligning technology with regenerative medicine workflows, the intervention enhances overall operational efficiency (Wolfien et al., 2023).
The proposed strategy includes:
Creation of standardized digital intake templates
Comprehensive provider and nursing training on redesigned workflows
Integration of CDSS functionalities for lab alerting and diagnostic guidance (Khalil et al., 2025)
Scheduled interdisciplinary review meetings to evaluate CDSS-generated recommendations
Phased pilot implementation to ensure system stability and refine workflows (Klein, 2025)
The CDSS will offer differential diagnosis suggestions, flag abnormal biomarker trends, and align clinical recommendations with evidence-based regenerative medicine practices.
By standardizing intake and automating decision support, diagnostic variability is reduced, ensuring better adherence to evidence-based regenerative protocols. Enhanced tracking of biomarkers allows for more accurate diagnoses, supporting appropriate stem-cell or hormone therapies (Ghasroldasht et al., 2022).
Automated alerts help prevent missed critical laboratory results, and improved interdisciplinary communication reduces handoff errors, ensuring safer initiation of biologic or cellular interventions (White et al., 2023).
Early detection of underlying health imbalances can prevent costly complications and reduce redundant testing. Although upfront investment in technology is required, long-term cost savings are expected through improved operational efficiency and avoidance of high-cost acute care episodes.
Table 2
Projected Outcomes of CDSS Integration
| Domain | Expected Improvement | Regenerative Care Example |
|---|---|---|
| Quality | Increased diagnostic accuracy; fewer omissions | Early detection of micronutrient deficiencies |
| Safety | Automated alerts for abnormal labs | Prevention of untreated hormonal imbalances |
| Cost | Reduced redundant testing and emergency visits | Avoidance of $8,000–$15,000 acute care episodes |
Technology serves as the backbone of this intervention. CDSS integration within the EHR provides real-time guidance, including lab flagging, differential diagnosis support, and treatment recommendations (Derksen et al., 2025). These systems reduce clinician cognitive burden, enhance recognition of longitudinal biomarker patterns, and promote transparency through shared dashboards. Additionally, data analytics enable continuous quality improvement, while ethical oversight ensures responsible application of regenerative treatments (Hermerén, 2021).
A staged implementation will begin with a pilot group of clinicians. Workflow mapping, simulation testing, and iterative refinement will occur before full organizational adoption (Klein, 2025).
Table 3
Anticipated Barriers and Mitigation Strategies
| Anticipated Barrier | Mitigation Strategy |
|---|---|
| Staff resistance | Structured training programs and change management initiatives |
| Budget limitations | Phased licensing and academic partnerships |
| Technical integration issues | Pre-implementation testing and close IT collaboration (Makhni & Hennekes, 2023) |
This approach minimizes disruption and supports sustainable adoption.
The successful implementation of CDSS requires coordinated participation from multiple disciplines:
Table 4
Interprofessional Contributions
| Role | Primary Responsibility | Application in Regenerative Care |
|---|---|---|
| Nurses & Nurse Practitioners | Conduct digital intake assessments | Identify contraindications for PRP or peptide therapy |
| Physicians | Establish diagnostic thresholds and treatment algorithms | Determine suitability for cellular-based interventions |
| IT Specialists | Configure and maintain EHR-CDSS systems | Establish regenerative-specific biomarker alerts |
| Administrative Personnel | Oversee training and compliance tracking | Coordinate interdisciplinary review meetings |
Collaborative governance ensures that technology and clinical pathways are effectively synchronized.
Integrating standardized digital intake protocols with a CDSS represents a strategic advancement for The Longevity Center. This approach reduces diagnostic delays, enhances workflow reliability, and embeds evidence-based guidance into regenerative medicine practices. A phased, interdisciplinary implementation ensures long-term sustainability, aligns operations with precision medicine standards, and optimizes patient outcomes.
Derksen, C., Walter, F. M., Akbar, A. B., Parmar, A. V. E., Saunders, T. S., Round, T., Rubin, G., & Scott, S. E. (2025). The implementation challenge of computerised clinical decision support systems for the detection of disease in primary care: Systematic review and recommendations. Implementation Science, 20, 1–33. https://doi.org/10.1186/s13012-025-01445-4
Ghasroldasht, M. M., Seok, J., Park, H.-S., Liakath Ali, F. B., & Al-Hendy, A. (2022). Stem cell therapy: From idea to clinical practice. International Journal of Molecular Sciences, 23(5). https://doi.org/10.3390/ijms23052850
Hermerén, G. (2021). The ethics of regenerative medicine. Biologia Futura, 72, 113–118. https://doi.org/10.1007/s42977-021-00075-3
Khalil, C., Saab, A., Rahme, J., Bouaud, J., & Seroussi, B. (2025). Capabilities of computerized decision support systems supporting the nursing process in hospital settings: A scoping review. BMC Nursing, 24(1). https://doi.org/10.1186/s12912-025-03272-w
Klein, N. J. (2025). Patient blood management through electronic health record [EHR] optimization (pp. 147–168). Springer Nature. https://doi.org/10.1007/978-3-031-81666-6_9
Makhni, E. C., & Hennekes, M. E. (2023). The use of patient-reported outcome measures in clinical practice and clinical decision making. The Journal of the American Academy of Orthopaedic Surgeons, 31(20), 1059–1066. https://doi.org/10.5435/JAAOS-D-23-00040
Sierra, Á., Kim, K. H., Morente, G., & Santiago, S. (2021). Cellular human tissue-engineered skin substitutes investigated for deep and difficult to heal injuries. Regenerative Medicine, 6(1), 1–23. https://doi.org/10.1038/s41536-021-00144-0
White, N., Carter, H. E., Borg, D. N., Brain, D. C., Tariq, A., Abell, B., Blythe, R., & McPhail, S. M. (2023). Evaluating the costs and consequences of computerized clinical decision support systems in hospitals: A scoping review and recommendations for future practice. Journal of the American Medical Informatics Association, 30(6), 1205–1218. https://doi.org/10.1093/jamia/ocad040
Wolfien, M., Ahmadi, N., Fitzer, K., Grummt, S., Heine, K.-L., Jung, I.-C., Krefting, D., Kuhn, A. N., Peng, Y., Reinecke, I., Scheel, J., Schmidt, T., Schmücker, P., Schüttler, C., Waltemath, D., Zoch, M., & Sedlmayr, M. (2023). Ten topics to get started in medical informatics research. Journal of Medical Internet Research, 25. https://doi.org/10.2196/45948
